Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11812
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Woods, Katherine | en |
dc.contributor.author | Cebon, Jonathan S | en |
dc.date.accessioned | 2015-05-16T01:26:26Z | |
dc.date.available | 2015-05-16T01:26:26Z | |
dc.date.issued | 2013-07-17 | en |
dc.identifier.citation | Clinical Cancer Research 2013; 19(15): 4021-3 | en |
dc.identifier.govdoc | 23864163 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/11812 | en |
dc.description.abstract | Despite success with immune checkpoint inhibitors, clinical benefit from cancer vaccines remains elusive. Combined targeting of melanoma-specific CD4(+) and CD8(+) T-lymphocyte epitopes was associated with improved survival compared with targeting either alone, or when a nonspecific helper epitope was used. We discuss the potential role of antigen-specific CD4 help. | en |
dc.language.iso | en | en |
dc.subject.other | Antigens, CD4.immunology | en |
dc.subject.other | CD4-Positive T-Lymphocytes | en |
dc.subject.other | CD8-Positive T-Lymphocytes | en |
dc.subject.other | Cancer Vaccines.immunology.therapeutic use | en |
dc.subject.other | Epitopes, T-Lymphocyte.immunology | en |
dc.subject.other | Flow Cytometry | en |
dc.subject.other | Humans | en |
dc.subject.other | Immunotherapy | en |
dc.subject.other | Lymphocyte Activation.immunology | en |
dc.subject.other | Melanoma.immunology.pathology.therapy | en |
dc.subject.other | Survival Analysis | en |
dc.title | Tumor-specific T-cell help is associated with improved survival in melanoma. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Clinical Cancer Research | en |
dc.identifier.affiliation | Ludwig Institute for Cancer Research Melbourne-Austin Branch, Heidelberg, Australia | en |
dc.identifier.doi | 10.1158/1078-0432.CCR-13-1349 | en |
dc.description.pages | 4021-3 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/23864163 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Cebon, Jonathan S | |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.